PMID- 10323341 OWN - NLM STAT- MEDLINE DCOM- 19990714 LR - 20190826 IS - 0001-2815 (Print) IS - 0001-2815 (Linking) VI - 53 IP - 4 Pt 1 DP - 1999 Apr TI - Contribution of TAP genes to genetic predisposition for diffuse panbronchiolitis. PG - 366-73 AB - Diffuse panbronchiolitis is a chronic obstructive pulmonary disease found in Asian populations. Although diffuse panbronchiolitis is considered to be a multifactorial disease of unknown etiology, the disease susceptibility appears to be determined by a genetic predisposition unique to Asians. An earlier study showed that human leukocyte antigen (HLA)-B54 predominantly found in East Asians was strongly associated with the disease. A possible interpretation of this association is that the class I molecule or class I antigen presenting system is directly involved in its pathogenesis. Recent observations in which impaired expression of class I molecules causes a syndrome resembling diffuse panbronchiolitis further prompted us to test this possibility. Genes of the molecules implicated in the class I pathway, TAP1, TAP2 and LMP2, which are located in the HLA region of the sixth chromosome were analyzed in 76 patients with diffuse panbronchiolitis and 120 normal controls. The combination of Ala-665 and Gln-687 in exon 11 of the TAP2 gene was associated with the disease (P=0.0028, Pc<0.05). Although this positive association might be partly explained by linkage disequilibrium with HLA-B*5401, this TAP2 variation was associated with the disease even in the B*5401-negative subgroup. On the other hand, the His-60 substitution within the LMP2 gene exhibited a negative association with the disease. This negative association, however, could be explained by a strong linkage disequilibrium with HLA-B44 which showed a negative association with the disease in the previous study. These results support the notion that diffuse panbronchiolitis is influenced by genetic factors in the HLA region. Besides the class I gene itself, genes relevant to the class I antigen presenting system might contribute to its genetic predisposition. FAU - Keicho, N AU - Keicho N AD - Department of Respiratory Medicine, University of Tokyo, Japan. KEICHO-3Im@h.u.tokyo.ac.jp FAU - Tokunaga, K AU - Tokunaga K FAU - Nakata, K AU - Nakata K FAU - Taguchi, Y AU - Taguchi Y FAU - Azuma, A AU - Azuma A FAU - Tanabe, K AU - Tanabe K FAU - Matsushita, M AU - Matsushita M FAU - Emi, M AU - Emi M FAU - Ohishi, N AU - Ohishi N FAU - Kudoh, S AU - Kudoh S LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - England TA - Tissue Antigens JT - Tissue antigens JID - 0331072 RN - 0 (ATP Binding Cassette Transporter, Subfamily B, Member 2) RN - 0 (ATP Binding Cassette Transporter, Subfamily B, Member 3) RN - 0 (ATP-Binding Cassette Transporters) RN - 0 (HLA-B Antigens) RN - 0 (Proteins) RN - 0 (TAP1 protein, human) RN - 144416-78-4 (LMP-2 protein) RN - 145892-13-3 (TAP2 protein, human) RN - EC 3.4.22.- (Cysteine Endopeptidases) SB - IM MH - ATP Binding Cassette Transporter, Subfamily B, Member 2 MH - ATP Binding Cassette Transporter, Subfamily B, Member 3 MH - ATP-Binding Cassette Transporters/*genetics MH - Alleles MH - Bronchiolitis/epidemiology/*genetics MH - *Cysteine Endopeptidases MH - Genetic Predisposition to Disease MH - HLA-B Antigens/*genetics MH - Humans MH - Japan/epidemiology MH - Polymorphism, Genetic MH - Proteins/*genetics EDAT- 1999/05/14 00:00 MHDA- 1999/05/14 00:01 CRDT- 1999/05/14 00:00 PHST- 1999/05/14 00:00 [pubmed] PHST- 1999/05/14 00:01 [medline] PHST- 1999/05/14 00:00 [entrez] AID - 10.1034/j.1399-0039.1999.530407.x [doi] PST - ppublish SO - Tissue Antigens. 1999 Apr;53(4 Pt 1):366-73. doi: 10.1034/j.1399-0039.1999.530407.x.